FDA Drug Shortage List
The vocabulary of getting a claim paid, of FDA enforcement, and of what on-label and off-label really mean.
What is FDA Drug Shortage List?
FDA's public register of medicines in short supply.
This market turned on it: while semaglutide and tirzepatide sat on it, compounding them at scale was lawful under the shortage exemption. Tirzepatide came off in late 2024 and semaglutide in February 2025, and the compounding that continues now rests on narrower ground.
Related reading: How Much Does Compounded Semaglutide Cost? What Drives the Number
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where FDA Drug Shortage List comes up on this site
Connected terms
Other terms under Insurance and regulatory
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers